Monogram Orthopaedics, Inc. (MGRM) Stock Analysis & Investment Frameworks
Monogram Orthopaedics, Inc. (MGRM) stock analysis on Invetso. Review Monogram Orthopaedics, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Monogram Orthopaedics, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Monogram Orthopaedics, Inc. Key Financial Metrics
- Market Cap: $243.79M
- Revenue: $N/A
- ROE: -117.05%
- ROIC: -93.54%
- Dividend Yield: N/A
About Monogram Orthopaedics, Inc.
Monogram Orthopaedics, Inc. (MGRM) specializes in developing technologies that enable the mass personalization and optimization of orthopedic implants. The company's strategy involves producing and marketing a comprehensive array of tools for reconstructive joint replacement surgeries, including advanced robotic surgical equipment with integrated software, specialized orthopedic implants, tissue ablation instruments, navigation consumables, and other related surgical accessories. Demonstrating its capabilities, a prototype robot precisely places optimized implants into synthetic bone specimens by executing carefully planned surgical pathways. The company was founded in 2016 and was initially known as Monogram Arthroplasty Inc. before officially rebranding to Monogram Orthopaedics, Inc. in March 2017. Its corporate headquarters are located in Austin, Texas.